AELIS FARMA SAS EO -,004Share · FR0014007ZB4 · A3DE66 (XPAR) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of AELIS FARMA SAS EO -,004
No Price
Closing Price XPAR 30.04.2026:
1,28 EUR
30.04.2026 14:17
Current Prices from AELIS FARMA SAS EO -,004
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
Paris
AELIS.PA
EUR
30.04.2026 14:17
1,28 EUR
-
Düsseldorf
AFSASAB4.DUSB
EUR
30.04.2026 06:11
1,21 EUR
-
Quotrix
AFSASAB4.DUSD
EUR
30.04.2026 05:27
1,24 EUR
-
Share Float & Liquidity
Free Float30,52 %
Shares Float4,16 M
Shares Outstanding13,63 M
Company Profile for AELIS FARMA SAS EO -,004 Share
Aelis Farma SA, a biotechnology company, engages in the research and development of treatments for brain diseases. It is developing signaling-specific inhibitors of the CB1 receptors, such as AEF0117, a drug candidate, which is in Phase 2b clinical trials for the treatment of the harmful effects of excessive cannabis use; and AEF0217, a drug candidate, which completed Phase 1 clinical trials to treat cognitive deficits observed in Down syndrome, as well as other cognitive impairments. The company was incorporated in 2013 and is based in Bordeaux, France.
